S100A7 and carcinoma: Of the 72 skin SCC specimens we evaluated, 90.2% (65/72) were well or moderately differentiated carcinomas and the sixty-four specimens were positive for S100A7 expression, whereas none of the six poorly differentiated carcinomas expressed S100A7.